This is not a cravings loss drug but largely a cravings management drug. Which is still pretty great but it saddles healthcare funding systems with an enormous burden for the next 20 years.
Semaglutide goes off-patent in 2032 in the US, and in 2026 in Canada and China:
No they have been on the market for decades, but only recently have been found to be of use to non-diabetics. That's why you are hearing about them much more.
Semaglutide goes off-patent in 2032 in the US, and in 2026 in Canada and China:
https://journals.library.columbia.edu/index.php/stlr/blog/vi...
https://www.ncbi.nlm.nih.gov/books/NBK602920/table/t03/